VR Pupillometry in Cognitive Impairment — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

VR Pupillometry in Cognitive Impairment — Stella

Home/Alzheimer s Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer s Disease trials

Trial locations(1 site)

Germany

Max Planck Institute of Psychiatry, München, Bavaria

Key details

Sponsor

Max-Planck-Institute of Psychiatry

Enrollment target

~140 participants

Started

May 2025

Primary completion

December 2027

Age range

18 Years – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.